SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological ...

SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced a strategic transaction to exclusively ...

NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter ...

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the launch of a Single Cell Gene ...

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein ...

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced the commercial unveiling of the nCounter Pro Analysis System, the next ...

Merck ($MRK) announced that it will deploy NanoString Technologies' ($NSTG) nCounter Analysis System as it searches for more genes that predict response to its ...

Presentations Include Data from More than Thirty NanoString-Related Abstracts Including Five Using the GeoMx Digital Spatial Profiler “Immunotherapy represents one of the most exciting fields for ...

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, has filed to raise $55 million through a secondary stock offering. The filing comes seven ...